TY - JOUR
T1 - Recognition and management of complications of new recreational drug use
AU - Ricaurte, George A.
AU - McCann, Una D.
N1 - Funding Information:
We thank C Bentley and P Rosenblatt for their assistance in preparing the manuscript. Our research was supported by the US Public Health Service (USPHS) through National Institute of Health (NIH) grants DA5707, DA13790, DA09487, DA00206, and DA10217. Both authors had final responsibility for the decision to submit for publication.
PY - 2005/6/18
Y1 - 2005/6/18
N2 - Use of illicit drugs in clubs and large dance parties (so-called raves) is a burgeoning cultural trend. Such recreational drug use is associated with several medical complications, both acute and longlasting. Although few, if any, of the drugs currently used in recreational venues are truly new, their patterns and context of use have changed (a great deal in some instances). For some of these substances, this cultural repackaging of the drug experience has resulted in various medical disorders that have previously gone undocumented. This review aims to help treating physicians recognise and manage complications associated with the use of new drugs in clubs, including methylenedioxymethamfetamine, ephedrine, γ-hydroxybutyrate; γ-butyrolactone, 1,4-butanediol, flunitrazepam, ketamine, and nitrites. We also alert researchers to specific toxic effects of club-drugs on which more basic information is needed.
AB - Use of illicit drugs in clubs and large dance parties (so-called raves) is a burgeoning cultural trend. Such recreational drug use is associated with several medical complications, both acute and longlasting. Although few, if any, of the drugs currently used in recreational venues are truly new, their patterns and context of use have changed (a great deal in some instances). For some of these substances, this cultural repackaging of the drug experience has resulted in various medical disorders that have previously gone undocumented. This review aims to help treating physicians recognise and manage complications associated with the use of new drugs in clubs, including methylenedioxymethamfetamine, ephedrine, γ-hydroxybutyrate; γ-butyrolactone, 1,4-butanediol, flunitrazepam, ketamine, and nitrites. We also alert researchers to specific toxic effects of club-drugs on which more basic information is needed.
UR - http://www.scopus.com/inward/record.url?scp=20444498341&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=20444498341&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(05)66737-2
DO - 10.1016/S0140-6736(05)66737-2
M3 - Review article
C2 - 15964451
AN - SCOPUS:20444498341
SN - 0140-6736
VL - 365
SP - 2137
EP - 2145
JO - Lancet
JF - Lancet
IS - 9477
ER -